Constant Therapy Health
Constant Therapy Health is a Boston-based digital therapeutics company that delivers AI-personalized speech, language, and cognitive therapy to patients recovering from stroke, TBI, aphasia, and other neurological conditions via its patented NeuroPerformance Engine and FDA Breakthrough-designated app.
- Company typePrivate
- Founded2014
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Constant Therapy Health does
Constant Therapy Health is a private digital therapeutics company founded in 2014 (originally as The Learning Corp) and headquartered in Lexington, Massachusetts. The company develops Constant Therapy, an AI-driven mobile and web application that delivers personalized speech, language, and cognitive therapy exercises to patients recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. The platform is powered by the patented NeuroPerformance Engine (NPE), which uses machine learning and population-level performance data from more than 140 million completed exercises to adapt exercise difficulty and selection to each user's diagnosis, severity, and progress. The product has been granted FDA Breakthrough Device designation for its Speech Therapy app, the first cognitive linguistics app to receive this regulatory status.
The company sells through a three-tier subscription model: a direct-to-consumer Patient tier at $29.99 per month after a 14-day free trial, a Partner Program for individual clinicians and small practices at $360 per clinician per year, and an Enterprise tier for hospitals, health systems, and large clinics with custom pricing, SSO, BAA, and population-level reporting. Distribution is hybrid: self-serve via the iOS App Store and Google Play for patients, and sales-led for institutional customers, with named partners including Burke Rehabilitation, VitalCaring, Elara Caring, Aviv Scientific, and Boundless AT, plus research collaborations with Boston University, University of Rochester, and University of Texas. The platform is available in English (US), English (India), and Spanish (US), and the company supports US and India operations via dedicated support lines.
Constant Therapy Health has raised approximately $30M in disclosed funding, most recently a $27.3M round in 2019. The company is led by founders Veera Anantha (CEO), Mahendra Advani (CTO), and Dr. Swathi Kiran (Founding Scientist, Boston University), and has been recognized among TIME's World's Top HealthTech Companies of 2025 and as a winner of the Hearst Health Prize. Its competitive position rests on the patented NPE, a regulatory moat from the FDA Breakthrough Device designation, a comprehensive evidence-based exercise library, and a growing real-world dataset.
Constant Therapy Health firmographics
Firmographics- Name
- Constant Therapy Health
- Legal name
- Constant Therapy Health
- Website
- https://constanttherapyhealth.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Constant Therapy Health is a Boston-based digital therapeutics company that delivers AI-personalized speech, language, and cognitive therapy to patients recovering from stroke, TBI, aphasia, and other neurological conditions via its patented NeuroPerformance Engine and FDA Breakthrough-designated app.
- Ownership category
- akta.pro rank
Constant Therapy Health industry classification
Industry- Product category
- Digital Therapeutics / Healthcare AI Software
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Services for the Elderly and Persons with Disabilities (62412)
- SIC
- Services-Misc Health & Allied Services, Nec (8090), Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK), Cognitive-Communication & Memory Rehab Therapy In-Home (HSABADAL)
Keywords
Where Constant Therapy Health is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Constant Therapy Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Patient Subscription: Individual patients pay $29.99/month for unlimited access to the Constant Therapy app after a 14-day free trial. Revenue generated through recurring monthly subscriptions with 30-day money-back guarantee.
- Partner Program - Clinicians: Individual clinicians or small practices (fewer than 5 clinicians) pay $360 per clinician annually for access to the Constant Therapy Clinician App with unlimited patients, progress reports, and patient management features.
- Enterprise Licensing: Mid-size and large healthcare entities pay variable fees based on number of users for enterprise features including population-level reporting, admin dashboards, SSO, BAA, and dedicated account managers.
- Technology Licensing: Licensing the Constant Therapy technology platform to healthcare enterprises, research institutions, and care delivery organizations through custom-built versions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Personal - Free for personal/light use |
| Subscription | Annual | Partner - $360 per clinician annually |
| Subscription | Multi-year contract | Enterprise - Custom pricing based on users |
| Subscription | Monthly | Patient - $29.99 per month |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Constant Therapy Health product offering
Product offeringCore offering
Constant Therapy Health develops and sells an AI-driven digital therapeutics platform called Constant Therapy that delivers personalized speech, language, and cognitive therapy exercises for individuals recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. The platform is offered to individual patients as a mobile subscription app, to speech-language pathologists via a clinician app, and to healthcare institutions (hospitals, health systems, clinics) through enterprise licensing with HIPAA-compliant security, population-level reporting, and EMR-ready documentation.
Product overview
Constant Therapy Health offers Constant Therapy, an AI-driven digital therapeutics platform for brain health. The core product suite includes: (1) Constant Therapy Patient App for direct consumer use with 80+ evidence-based speech, language, and cognitive exercises; (2) Constant Therapy Clinician for speech-language pathologists to assign and monitor therapy; (3) Constant Therapy Enterprise for institutional deployment across hospitals and clinics with HIPAA-compliant security, admin controls, and EMR documentation; and (4) the NeuroPerformance Engine (NPE), the patented AI technology powering all products that delivers personalized exercise recommendations by analyzing individual performance against population data. The platform is complemented by the BrainWire educational blog and is available in English (US), English (India), and Spanish (US).
Differentiator
Problem solved
Functional benefit
Brands
- Constant Therapy Enterprise: Enterprise solution for clinics and healthcare organizations providing cognitive and speech therapy with HIPAA-compliant features, admin controls, and EMR-ready documentation.
- Constant Therapy Clinician
- Constant Therapy Patient App
Products and services
- Constant Therapy Patient App Mobile application for individuals recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. Provides 24/7 access to over 80 evidence-based speech, language, and cognitive therapy exercises across 14+ categories with adaptive difficulty that adjusts based on the user's performance and progress. Available on smartphone, tablet, and Chromebook.
- Constant Therapy Clinician Evidence-based digital program for speech-language pathologists (SLPs) and adult speech therapists to deliver interactive cognitive and speech therapy in clinic and assign personalized home exercise programs to patients. Includes detailed progress reporting, auto-generated clinical documentation, and caseload management features.
- Constant Therapy Enterprise Institutional deployment of the Constant Therapy platform for hospitals, rehabilitation centers, health systems, and large clinics. Includes unlimited patients, population-level reporting, admin dashboard, priority support, SSO, MFA, password policy, IP whitelisting, Business Associates Agreement (BAA), flexible license assignment, and EMR-ready auto-generated clinical documentation. Sold via custom multi-year contracts through the enterprise sales team.
Quantifiable outcome
- 4x more therapy delivered compared to clinic-only care
- +4 more outcomes
Companies that use Constant Therapy Health
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
Constant Therapy Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability6 records
Feature5 records
Constant Therapy Health partnerships and signals
Strategic signalScale indicators7 records
Recent moves6 records
Expansion highlights5 records
Constant Therapy Health competitors and assessment
Company assessmentDirect peers
- Pear Therapeutics: Pear Therapeutics was a pioneer in prescription digital therapeutics (reSET, reSET-O) for substance use disorder and opioid use disorder. It is a relevant direct peer in FDA-authorized digital therapeutics, though it filed for bankruptcy in 2023, illustrating the commercial challenges in the category.
- MedRhythms: MedRhythms builds digital therapeutics for neurologic conditions, focusing on gait and walking recovery post-stroke using sensor-based interventions. It is a direct peer in prescription digital therapeutics for neurorehabilitation.
- Posit Science (BrainHQ): Posit Science offers BrainHQ, an evidence-based cognitive training platform with clinician and consumer versions. It is directly comparable as a digital cognitive training product serving both patients recovering from neurological conditions and healthy adults seeking cognitive improvement.
- Akili Interactive: Akili Interactive (now folded into Virtual Therapeutics) develops FDA-cleared digital therapeutics for cognitive dysfunction, including EndeavorRx for ADHD. It is a direct peer as a prescription and consumer digital therapeutic targeting neurological and cognitive conditions.
- Big Health: Big Health develops digital therapeutics for mental health conditions such as insomnia (Sleepio) and anxiety. It is comparable as a digital therapeutics company with both consumer and enterprise/health plan distribution and FDA-recognized evidence base.
Emerging players
- Limbic: Limbic is a UK-based AI mental health platform used by NHS talking therapy services for patient intake, triage, and outcome measurement. It is an emerging player using AI in behavioral health workflows, with overlapping technology and clinical use cases though focused on mental health rather than neurocognitive rehab.
Broad incumbents
- Teladoc Health: Teladoc Health operates a broad virtual care platform spanning general telehealth, mental health, and chronic condition management. It is comparable as a large incumbent digital health player that health systems and employers buy alongside or against Constant Therapy.
- Omada Health: Omada Health provides digital care programs for chronic conditions (diabetes, hypertension, musculoskeletal). It is a broad incumbent in digital therapeutics selling to employers and health plans, comparable in enterprise GTM and evidence-based care delivery.
- Headspace Health: Headspace Health (Headspace + Ginger) offers a broad mental health and wellness platform including therapy, coaching, and meditation. It is comparable as a digital health company serving consumers and enterprises with brain/mental health content, though its scope is broader than neurocognitive rehabilitation.
- Talkspace: Talkspace is an online therapy platform connecting users to licensed therapists via text, audio, and video. It is comparable as a digital mental/behavioral health platform selling to both consumers and enterprises/B2B partners, though its modality is live human therapy rather than AI-driven exercises.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Constant Therapy Health social profiles
Digital presenceConstant Therapy Health compliance and trust
Trust signalCompliance1 record
Constant Therapy Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Constant Therapy Health leadership team
Management profileNumber of profiles
Profiles7 records
Constant Therapy Health funding detail
Funding detailFunding overview
Funding rounds5 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Constant Therapy Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Constant Therapy Health
What does Constant Therapy Health do?
Constant Therapy Health develops and sells an AI-driven digital therapeutics platform called Constant Therapy that delivers personalized speech, language, and cognitive therapy exercises for individuals recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. The platform is offered to individual patients as a mobile subscription app, to speech-language pathologists via a clinician app, and to healthcare institutions (hospitals, health systems, clinics) through enterprise licensing with HIPAA-compliant security, population-level reporting, and EMR-ready documentation.
Is Constant Therapy Health a public or private company?
Constant Therapy Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Constant Therapy Health founded?
Constant Therapy Health was founded in 2014. It employs 11 to 50 people.
Where is Constant Therapy Health based?
Constant Therapy Health is headquartered in Boston, United States, in the North America region.
How does Constant Therapy Health make money?
Four revenue lines are on record. Patient Subscription is the primary driver. The others are partner Program - Clinicians, enterprise Licensing and technology Licensing.
Who are Constant Therapy Health's main competitors?
Direct peers on record are Pear Therapeutics, MedRhythms, Posit Science (BrainHQ), Akili Interactive and Big Health. Limbic is listed as an emerging player. Broad incumbents are Teladoc Health, Omada Health, Headspace Health and Talkspace.
Does Constant Therapy Health have an API?
No public API is recorded for Constant Therapy Health.
What industry is Constant Therapy Health in?
Constant Therapy Health's product category is Digital Therapeutics / Healthcare AI Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 62134 and its SIC code is 8090.